Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Natalino Simioni"'
Autor:
Gian Paolo Fadini, Vera Frison, Natalino Simioni, Annunziata Lapolla, Adriano Gatti, Antonio Carlo Bossi, Andrea Del Buono, Paolo Fornengo, Lucia Gottardo, Mario Laudato, Gianluca Perseghin, Enzo Bonora, Angelo Avogaro
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 14 (2019)
Background Evidence accumulated that some glucose‐lowering medications protect against cardiovascular events (CVEs) in patients with type 2 diabetes mellitus (T2DM) and established cardiovascular disease. The present study evaluated if and how gluc
Externí odkaz:
https://doaj.org/article/59e2c8b2a3aa46b5b9f78c3ddf8c5d8d
Autor:
Natalino Simioni
Publikováno v:
Italian Journal of Medicine, Vol 10, Iss 2, Pp 103-110 (2016)
The management of hospitalized diabetic patients for any cause is often difficult and affected not only by the comorbidities of the patient but also by the hospital setting. It is well known that at the admission the antidiabetic drugs should be disc
Externí odkaz:
https://doaj.org/article/b6333be329e04b1f832d4c2ec8871205
Patient not adequately controlled with insulin therapy and hospitalized for congestive heart failure
Publikováno v:
AboutOpen, Vol 4, Iss 1 (2018)
The data provided by cardiovascular safety studies of type 2 sodium-glucose transporter inhibitors have aroused great interest among diabetologists and other specialists. They demonstrated that these drugs reduce significantly, compared to placebo, t
Externí odkaz:
https://doaj.org/article/381a2133ecf24c5cb7e223a7aca02c10
Publikováno v:
Italian Journal of Medicine, Vol 3, Iss 2, Pp 82-87 (2013)
BACKGROUND Diabetes is known to be a major contributor to blindness in industrialized countries in adults. In addition to glycemic control, arterial hypertension is emerging as important factor in the development and progression of diabetic retinopat
Externí odkaz:
https://doaj.org/article/6b036e84017f48ba9644fcf4ee22d334
Publikováno v:
Italian Journal of Medicine, Vol 8, Iss 4, Pp 262-264 (2014)
A 59-year old woman was admitted for fatigue and arm paresthesias with Trousseau sign. Her medical history included thyroidectomy and hypercholesterolemia recently treated with simvastatin. Laboratory tests showed severe hypokalemia and hypocalcemia,
Externí odkaz:
https://doaj.org/article/3cdf4eb58d02445ca709e8f46cab0327
Autor:
Gloria Groppelli, Andrea Da Porto, Valeria Guazzoni, Vera Frison, Massimo Bracaccia, Francesca Lugli, Luciano Zenari, Barbara Bonsembiante, Lorena De Moliner, Natalino Simioni, Cesare Miranda, Annunziata Lapolla, Laura Molteni
Publikováno v:
Diabetes Therapy
Introduction Combination therapy with both basal insulin (BI) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) is an effective treatment in patients with uncontrolled type 2 diabetes mellitus (T2DM). The recent development and release of a fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57d0ff0f7ae623d0f342f05398838c7c
https://doi.org/10.1007/s13300-020-00945-4
https://doi.org/10.1007/s13300-020-00945-4
Autor:
Mario Luca Morieri, Angelo Avogaro, Natalino Simioni, Agostino Paccagnella, Michele D'Ambrosio, Federica Tadiotto, Annunziata Lapolla, Mauro Rigato, Vera Frison, Gian Paolo Fadini
Publikováno v:
Acta Diabetologica. 57:367-375
Several GLP-1 receptor agonists (GLP-1RA) have become available for the treatment of type 2 diabetes (T2D), and evidence on their beneficial effects has evolved. We evaluated how the clinical phenotype of patients initiating GLP-1RA changed from 2010
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::779c57d5314ecd711cc20aeda718aab9
https://doi.org/10.1007/s00592-019-01445-z
https://doi.org/10.1007/s00592-019-01445-z
Autor:
Annunziata Lapolla, Paola Silvia Morpurgo, B. Fattor, Angelo Avogaro, Natalino Simioni, Bendetta Maria Bonora, Gian Paolo Fadini
Publikováno v:
Diabetes, Obesity & Metabolism
In this study, we retrospectively compared the effectiveness of exenatide once-weekly (ExeOW) versus liraglutide in non-insulin treated patients with type 2 diabetes followed under routine care. We also present a meta-analysis of similar observationa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51182b10748dbff17e43e19138cb6946
https://doi.org/10.1111/dom.13623
https://doi.org/10.1111/dom.13623
Autor:
Federica Tadiotto, Giovanni Targher, Mario Luca Morieri, Angelo Avogaro, Michele D'Ambrosio, Vera Frison, Mauro Rigato, Gian Paolo Fadini, Natalino Simioni, Agostino Paccagnella, Annunziata Lapolla
Publikováno v:
Nutrition, metabolism, and cardiovascular diseases : NMCD. 31(12)
Aims Metabolic dysfunction-associated fatty liver disease (MAFLD) is common in people with type 2 diabetes (T2D) and can progress to advanced fibrosis and cirrhosis. In this retrospective study, we explored the longitudinal changes in markers of hepa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029e7d2bb5202560a4710b7f86336c19
https://pubmed.ncbi.nlm.nih.gov/34629258
https://pubmed.ncbi.nlm.nih.gov/34629258
Autor:
Sciannameo, V., Berchialla, P., Avogaro, A., Fadini, G. P., DARWIN-T2D Network: Agostino Consoli, Gloria, Formoso, Giovanni, Grossi, Achiropita, Pucci, Giorgio, Sesti, Francesco, Andreozzi, Giuseppe, Capobianco, Adriano, Gatti, Riccardo, Bonadonna, Ivana, Zavaroni, Alessandra, Deicas, Giuseppe, Felace, Patrizia Li Volsi, Raffaella, Buzzetti, Gaetano, Leto, Gian Pio Sorice, Paola, D'Angelo, Susanna, Morano, Antonio Carlo Bossi, Edoardo, Duratorre, Ivano, Franzetti, Paola Silvia Morpurgo, Emanuela, Orsi, Fabrizio, Querci, Massimo, Boemi, Federica, D'Angelo, Massimiliano, Petrelli, Gianluca, Aimaretti, Ioannis, Karamouzis, Franco, Cavalot, Giuseppe, Saglietti, Giuliana, Cazzetta, Silvestre, Cervone, Eleonora, Devangelio, Olga, Lamacchia, Salvatore, Arena, Antonino Di Benedetto, Frittitta, Lucia, Carla, Giordano, Piro, Salvatore, Manfredi, Rizzo, Roberta, Chianetta, Carlo, Mannina, Roberto, Anichini, Giuseppe, Penno, Anna, Solini, Bruno, Fattor, Enzo, Bonora, Massimo, Cigolini, Annunziata, Lapolla, Nino Cristiano Chilelli, Natalino, Simioni, Vera, Frison, Carmela, Vinci.
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-9 (2021)
Cardiovascular Diabetology
Cardiovascular Diabetology
Background Transferring results obtained in cardiovascular outcome trials (CVOTs) to the real-world setting is challenging. We herein transposed CVOT results to the population of patients with type 2 diabetes (T2D) seen in routine clinical practice a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fb5ea41c06b7f83f1a011633d41c5da
http://hdl.handle.net/2318/1789258
http://hdl.handle.net/2318/1789258
